The unique ligand binding features of subfamily-II iLBPs with respect to bile salts and related drugs

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 95, Issue , 2015, Pages 1-10

  Favretto, Filippo ^a   Ceccon, Alberto ^a   Zanzoni, Serena ^a   D'Onofrio, Mariapina ^a   Ragona, Laura ^b   Molinari, Henriette ^b   Assfalg, Michael ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b CNR   (Italy)

Author keywords

Bile acid binding protein; Bile salt transport; Intracellular lipid binding protein; NMR spectroscopy

Indexed keywords

BILE ACID; BILE SALT; CYTOPLASM PROTEIN; FATTY ACID BINDING PROTEIN; GADOLINIUM CHELATE; GLYCOCHOLIC ACID; ILEAL BILE ACID BINDING PROTEIN; LIVER BILE ACID BINDING PROTEIN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUBFAMILY II INTRACELLULAR LIPID BINDING PROTEIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; BILE ACID BINDING PROTEINS; CARRIER PROTEIN; CONTRAST MEDIUM; MEMBRANE PROTEIN; SURFACTANT;

BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DISSOCIATION CONSTANT; DISULFIDE BOND; HUMAN; INTERNALIZATION; INTRACELLULAR TRANSPORT; LIGAND BINDING; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; STOICHIOMETRY; THERMODYNAMICS; TISSUE DISTRIBUTION; ANIMAL; CHEMISTRY; METABOLISM; PROTEIN CONFORMATION;

ANIMALIA;

ANIMALS; BILE ACIDS AND SALTS; BINDING SITES; CARRIER PROTEINS; CONTRAST MEDIA; FATTY ACID-BINDING PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN CONFORMATION; SURFACE-ACTIVE AGENTS;

EID: 84924917657     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.10.005     Document Type: Review

References (52)

1. Schaap F.G., van der Vusse G.J., Glatz J.F.C. Evolution of the family of intracellular lipid binding proteins in vertebrates. Mol. Cell. Biochem. 2002, 239:69-77.
2. Haunerland N.H., Spener F. Fatty acid-binding proteins-insights from genetic manipulations. Prog. Lipid Res. 2004, 43:328-349.
3. Marcelino A.M.C., Smock R.G., Gierasch L.M. Evolutionary coupling of structural and functional sequence information in the intracellular lipid-binding protein family. Proteins 2006, 63:373-384.
4. Hofmann A.F., Hagey L.R. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci. 2008, 65:2461-2483.
5. Lefebvre P., Cariou B., Lien F., Kuipers F., Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 2009, 89:147-191.
6. Zwicker B.L., Agellon L.B. Transport and biological activities of bile acids. Int. J. Biochem. Cell Biol. 2013, 45:1389-1398.
7. Coe N.R., Bernlohr D.A. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta 1998, 1391:287-306.
8. Chuang S., Velkov T., Horne J., Porter C.J.H., Scanlon M.J. Characterization of the drug binding specificity of rat liver fatty acid binding protein. J. Med. Chem. 2008, 51:3755-3764.
9. Assfalg M., Gianolio E., Zanzoni S., Tomaselli S., Russo V.L., Cabella C., et al. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent. J. Med. Chem. 2007, 50:5257-5268.
10. Tomaselli S., Zanzoni S., Ragona L., Gianolio E., Aime S., Assfalg M., et al. Solution structure of the supramolecular adduct between a liver cytosolic bile acid binding protein and a bile acid-based gadolinium(III)-chelate, a potential hepatospecific magnetic resonance imaging contrast agent. J. Med. Chem. 2008, 51:6782-6792.
11. D'Onofrio M., Gianolio E., Ceccon A., Arena F., Zanzoni S., Fushman D., et al. High relaxivity supramolecular adducts between human-liver fatty-acid-binding protein and amphiphilic GdIII complexes: structural basis for the design of intracellular targeting MRI probes. Chemistry-Eur. J. 2012, 18:9919-9928.
12. van der Velden L.M., Golynskiy M.V., Bijsmans I.T.G.W., van Mil S.W.C., Klomp L.W.J., Merkx M., et al. Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor. Hepatology 2013, 57:740-752.
13. Martin G.G., Atshaves B.P., McIntosh A.L., Mackie J.T., Kier A.B., Schroeder F. Liver fatty-acid-binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice. Biochem. J. 2005, 391:549-560.
14. Xie Y., Newberry E.P., Kennedy S.M., Luo J., Davidson N.O. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. J. Lipid Res. 2009, 50:977-987.
15. Praslickova D., Torchia E.C., Sugiyama M.G., Magrane E.J., Zwicker B.L., Kolodzieyski L., et al. The ileal lipid binding protein is required for efficient absorption and transport of bile acids in the distal portion of the murine small intestine. PLoS ONE 2012, 7:e50810.
16. Kok T., Hulzebos C.V., Wolters H., Havinga R., Agellon L.B., Stellaard F., et al. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J. Biol. Chem. 2003, 278:41930-41937.
17. Monaco H.L. Review: the liver bile acid-binding proteins. Biopolymers 2009, 91:1196-1202.
18. Guariento M., Raimondo D., Assfalg M., Zanzoni S., Pesente P., Ragona L., et al. Identification and functional characterization of the bile acid transport proteins in non-mammalian ileum and mammalian liver. Proteins 2008, 70:462-472.
19. Tomaselli S., Giovanella U., Pagano K., Leone G., Zanzoni S., Assfalg M., et al. Encapsulation of a rhodamine dye within a bile acid binding protein: toward water processable functional bio host-guest materials. Biomacromolecules 2013, 14:3549-3556.
20. Lücke C., Zhang F., Rüterjans H., Hamilton J.A., Sacchettini J.C. Flexibility is a likely determinant of binding specificity in the case of ileal lipid binding protein. Structure 1996, 4:785-800.
21. Lücke C., Zhang F., Hamilton J.A., Sacchettini J.C., Rüterjans H. Solution structure of ileal lipid binding protein in complex with glycocholate. Eur. J. Biochem. 2000, 267:2929-2938.
22. Kurz M., Brachvogel V., Matter H., Stengelin S., Thüring H., Kramer W. Insights into the bile acid transportation system: the human ileal lipid-binding protein-cholyltaurine complex and its comparison with homologous structures. Proteins 2003, 50:312-328.
23. Tochtrop G.P., Richter K., Tang C., Toner J.J., Covey D.F., Cistola D.P. Energetics by NMR: site-specific binding in a positively cooperative system. Proc. Natl. Acad. Sci. USA 2002, 99:1847-1852.
24. Capaldi S., Saccomani G., Fessas D., Signorelli M., Perduca M., Monaco H.L. The X-ray structure of zebrafish (Danio rerio) ileal bile acid-binding protein reveals the presence of binding sites on the surface of the protein molecule. J. Mol. Biol. 2009, 385:99-116.
25. Kouvatsos N., Thurston V., Ball K., Oldham N.J., Thomas N.R., Searle M.S. Bile acid interactions with rabbit ileal lipid binding protein and an engineered helixless variant reveal novel ligand binding properties of a versatile beta-clam shell protein scaffold. J. Mol. Biol. 2007, 371:1365-1377.
26. Kramer W., Sauber K., Baringhaus K.H., Kurz M., Stengelin S., Lange G., et al. Identification of the bile acid-binding site of the ileal lipid-binding protein by photoaffinity labeling, matrix-assisted laser desorption ionization-mass spectrometry, and NMR structure. J. Biol. Chem. 2001, 276:7291-7301.
27. Turpin E.R., Fang H.-J., Thomas N.R., Hirst J.D. Cooperativity and site selectivity in the ileal lipid binding protein. Biochemistry 2013, 52:4723-4733.
28. Zanzoni S., Assfalg M., Giorgetti A., D'Onofrio M., Molinari H. Structural requirements for cooperativity in ileal bile acid-binding proteins. J. Biol. Chem. 2011, 286:39307-39317.
29. Eliseo T., Ragona L., Catalano M., Assfalg M., Paci M., Zetta L., et al. Structural and dynamic determinants of ligand binding in the ternary complex of chicken liver bile acid binding protein with two bile salts revealed by NMR. Biochemistry 2007, 46:12557-12567.
30. Favretto F., Assfalg M., Gallo M., Cicero D.O., D'Onofrio M., Molinari H. Ligand binding promiscuity of human liver fatty acid binding protein: structural and dynamic insights from an interaction study with glycocholate and oleate. ChemBioChem 2013, 14:1807-1819.
31. Di Cera E. Thermodynamic Theory of Site-Specific Binding Processes in Biological Macromolecules 1995, Cambridge University Press, Cambridge{plus 45 degree rule}New York.
32. Forsén S., Linse S. Cooperativity: over the Hill. Trends Biochem. Sci. 1995, 20:495-497.
33. Tochtrop G.P., DeKoster G.T., Covey D.F., Cistola D.P. A single hydroxyl group governs ligand site selectivity in human ileal bile acid binding protein. J. Am. Chem. Soc. 2004, 126:11024-11029.
34. Tomaselli S., Ragona L., Zetta L., Assfalg M., Ferranti P., Longhi R., et al. NMR-based modeling and binding studies of a ternary complex between chicken liver bile acid binding protein and bile acids. Proteins 2007, 69:177-191.
35. Pedò M., D'Onofrio M., Ferranti P., Molinari H., Assfalg M. Towards the elucidation of molecular determinants of cooperativity in the liver bile acid binding protein. Proteins 2009, 77:718-731.
36. Ragona L., Catalano M., Luppi M., Cicero D., Eliseo T., Foote J., et al. NMR dynamic studies suggest that allosteric activation regulates ligand binding in chicken liver bile acid-binding protein. J. Biol. Chem. 2006, 281:9697-9709.
37. Toke O., Monsey J.D., DeKoster G.T., Tochtrop G.P., Tang C., Cistola D.P. Determinants of cooperativity and site selectivity in human ileal bile acid binding protein. Biochemistry 2006, 45:727-737.
38. Guariento M., Assfalg M., Zanzoni S., Fessas D., Longhi R., Molinari H. Chicken ileal bile-acid-binding protein: a promising target of investigation to understand binding co-operativity across the protein family. Biochem. J. 2010, 425:413-424.
39. Toke O., Monsey J.D., Cistola D.P. Kinetic mechanism of ligand binding in human ileal bile acid binding protein as determined by stopped-flow fluorescence analysis. Biochemistry 2007, 46:5427-5436.
40. Cogliati C., Tomaselli S., Assfalg M., Pedò M., Ferranti P., Zetta L., et al. Disulfide bridge regulates ligand-binding site selectivity in liver bile acid-binding proteins. FEBS J. 2009, 276:6011-6023.
41. Cogliati C., Ragona L., D'Onofrio M., Günther U., Whittaker S., Ludwig C., et al. Site-specific investigation of the steady-state kinetics and dynamics of the multistep binding of bile acid molecules to a lipid carrier protein. Chemistry-Eur. J 2010, 16:11300-11310.
42. Horváth G., Király P., Tárkányi G., Toke O. Internal motions and exchange processes in human ileal bile acid binding protein as studied by backbone 15N nuclear magnetic resonance spectroscopy. Biochemistry 2012, 51:1848-1861.
43. Long D., Yang D. Millisecond timescale dynamics of human liver fatty acid binding protein: testing of its relevance to the ligand entry process. Biophys. J. 2010, 98:3054-3061.
44. Trevaskis N.L., Nguyen G., Scanlon M.J., Porter C.J.H. Fatty acid binding proteins: potential chaperones of cytosolic drug transport in the enterocyte?. Pharm. Res. 2011.
45. Furuhashi M., Hotamisligil G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 2008, 7:489-503.
46. Anelli P.L., Calabi L., de Haën C., Lattuada L., Lorusso V., Maiocchi A., et al. Hepatocyte-directed MR contrast agents. Can we take advantage of bile acids?. Acta Radiol. Suppl. 1997, 412:125-133.
47. Anelli P.L., Lattuada L., Lorusso V., Lux G., Morisetti A., Morosini P., et al. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging. J. Med. Chem. 2004, 47:3629-3641.
48. Nakahara M., et al. Ileal bile acid-binding protein, functionally associated with the farnesoid X receptor or the ileal bile acid transporter, regulates bile acid activity in the small intestine. J. Biol. Chem. 2005, 280:42283-42289.
49. Pedò M., Löhr F., D'Onofrio M., Assfalg M., Dötsch V., Molinari H. NMR studies reveal the role of biomembranes in modulating ligand binding and release by intracellular bile acid binding proteins. J. Mol. Biol. 2009, 394:852-863.
50. Storch J., Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu. Rev. Nutr. 2008, 28:73-95.
51. Ceccon A., D'Onofrio M., Zanzoni S., Longo D.L., Aime S., Molinari H., et al. NMR investigation of the equilibrium partitioning of a water-soluble bile salt protein carrier to phospholipid vesicles. Proteins 2013, 81:1776-1791.
52. Tomaselli S., Assfalg M., Pagano K., Cogliati C., Zanzoni S., Molinari H. A disulfide bridge allows for site-selective binding in liver bile acid binding protein thereby stabilising the orientation of key amino acid side chains. Chem.- Eur. 2012, J 18:2857-2866.